ARS Pharmaceuticals Balance Sheet (2021-2025) | SPRY

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Assets
Current Assets
Cash & Equivalents 374.20M359.69M300.66M60.06M233.99M218.69M203.22M210.52M87.86M119.02M60.53M70.97M56.01M36.63M39.66M50.82M39.86M51.54M59.56M
Short-term Investments 19.86M39.28M63.40M63.86M176.69M133.19M181.37M157.39M167.63M182.12M164.97M263.20M235.86M188.59M228.65M
Cash & Current Investments 374.20M359.69M300.66M60.06M253.85M257.98M266.62M274.38M264.55M252.21M241.90M228.36M223.63M218.74M204.62M314.02M275.73M240.13M288.21M
Receivables - Net 0.77M8.18M9.30M25.13M36.45M
Receivables - Other 0.16M0.21M0.31M0.35M0.21M0.65M0.28M0.12M0.15M1.23M0.96M2.03M4.27M
Receivables 0.93M9.41M10.27M27.15M40.72M
Raw Materials 0.42M
Work In Process 0.29M
Finished Goods 5.21M7.27M
Inventory 0.71M5.21M7.27M8.74M7.78M
Prepaid Assets 4.14M3.34M4.70M0.67M7.49M5.15M4.17M3.32M2.80M2.83M2.56M3.37M2.61M1.99M2.68M6.89M11.56M7.44M6.42M
Current Assets 378.35M363.03M305.36M60.73M261.33M263.13M270.80M277.70M267.35M255.03M244.47M231.73M226.24M220.74M208.79M334.30M303.86M281.44M338.86M
Non-Current Assets
Property, Plant & Equipment (Net) 1.60M1.98M1.91M0.07M2.43M2.48M0.01M0.33M0.58M0.59M0.62M0.57M0.62M0.64M0.84M1.03M1.07M1.07M1.21M
Long-Term Investments 39.94M64.78M43.97M24.22M
Intangibles 0.62M0.53M0.45M7.50M7.37M7.24M12.97M14.73M
Goodwill & Intangibles 0.62M0.53M0.45M7.50M7.37M7.24M12.97M14.73M
Long-Term Deferred Tax 29.04M36.86M
Other Non-Current Assets 0.35M0.35M0.35M0.02M0.25M0.25M2.40M2.96M2.86M2.77M3.17M0.64M0.53M0.45M0.38M3.11M3.13M3.05M2.92M
Non-Current Assets 3.85M3.95M47.21M0.72M51.14M30.87M0.27M3.73M3.84M3.72M4.09M1.46M1.34M1.23M8.81M16.86M23.46M32.04M33.94M
Assets 382.20M366.98M352.56M61.45M312.47M294.00M271.06M281.44M271.19M258.75M248.56M233.19M227.58M221.97M217.60M351.15M327.32M313.47M372.80M
Liabilities
Current Liabilities
Accounts Payables 4.37M1.80M1.72M3.11M2.63M2.11M0.13M4.93M9.60M9.82M10.95M2.15M3.50M6.57M16.52M22.84M27.01M44.26M49.77M
Notes Payables 3.48M
Payables 4.37M1.80M1.72M6.59M2.63M2.11M0.13M4.93M9.60M9.82M10.95M2.15M3.50M6.57M16.52M22.84M27.01M44.26M49.77M
Accumulated Expenses 5.80M12.79M12.54M11.73M11.05M8.15M3.65M2.29M11.27M
Other Accumulated Expenses 0.57M3.08M
Short term Debt 0.49M
Current Leases 0.93M0.96M1.09M0.14M1.12M0.88M0.21M0.23M0.23M0.23M0.23M0.24M0.22M0.16M0.10M0.04M0.07M0.59M0.58M
Current Deferred Revenue 1.46M3.14M0.01M0.56M0.54M0.75M0.53M
Total Current Liabilities 11.60M15.55M15.35M8.19M14.81M11.14M3.99M5.44M9.84M10.05M11.18M2.39M3.71M6.72M16.62M23.44M27.62M45.60M50.88M
Non-Current Liabilities
Non-Current Debt 4.93M
Non-Current Deffered Revenue 3.00M2.85M1.53M1.34M1.10M1.27M
Preferred Stock Liabilities 54.81M
Operating Leases 2.98M1.78M5.08M0.48M4.43M4.07M0.25M0.43M0.15M0.09M0.04M1.07M0.95M
Other Non-Current Liabilities 0.08M1.42M3.78M
Total Non-Current Liabilities 16.59M119.73M221.37M
Total Liabilities 13.65M17.33M20.43M16.68M19.24M15.21M3.99M8.55M10.04M10.20M11.27M2.43M3.71M6.72M16.62M94.36M98.34M121.15M225.15M
Shareholder's Equity
Total Debt 0.49M4.93M
Common Equity 368.55M349.65M332.13M-31.27M293.23M278.79M267.07M272.89M261.15M248.55M237.28M230.76M223.87M215.24M200.98M256.80M228.97M192.32M147.66M
Shareholder's Equity 368.55M349.65M332.13M-31.27M293.23M278.79M267.07M272.89M261.15M248.55M237.28M230.76M223.87M215.24M200.98M256.80M228.97M192.32M147.66M
Liabilities and Shareholders Equity 382.20M366.98M352.56M61.45M312.47M294.00M271.06M281.44M271.19M258.75M248.56M233.19M227.58M221.97M217.60M351.15M327.32M313.47M372.80M
Retained Earnings -115.60M-140.10M-162.80M-42.26M-210.84M-230.27M-248.14M-76.94M-91.90M-109.27M-124.14M-131.30M-141.59M-154.11M-173.24M-123.31M-157.25M-202.13M-253.28M